메뉴 건너뛰기




Volumn 200, Issue , 2011, Pages 93-133

Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds

Author keywords

Caffeine; Caffeine in beverages and foods; Cyclic AMP; Cyclic GMP; Phosphodiesterase inhibitors; Phosphodiesterases; Theophylline; Xanthine

Indexed keywords

ADENOCIRCA; CAFFEINE; CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; METHYLXANTHINE DERIVATIVE; PENTOXIFYLLINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; THEOPHYLLINE; UNCLASSIFIED DRUG; VARDENAFIL; XANTHINE DERIVATIVE;

EID: 77957596953     PISSN: 01712004     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-13443-2_4     Document Type: Review
Times cited : (62)

References (196)
  • 2
    • 77957571130 scopus 로고    scopus 로고
    • Pharmacokinetics and metabolism of natural methylxanthines in animal and man
    • Fredholm BB ed, Springer, Heidelberg
    • Arnaud M (2010) Pharmacokinetics and metabolism of natural methylxanthines in animal and man. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Arnaud, M.1
  • 3
    • 0021683734 scopus 로고
    • Pentoxifylline: A new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects
    • Aviado DM, Porter JM (1984) Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects. Pharmacotherapy 4:297-307
    • (1984) Pharmacotherapy , vol.4 , pp. 297-307
    • Aviado, D.M.1    Porter, J.M.2
  • 4
    • 0032445219 scopus 로고    scopus 로고
    • Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes
    • Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164-2171
    • (1998) J. Urol. , vol.159 , pp. 2164-2171
    • Ballard, S.A.1    Gingell, C.J.2    Tang, K.3    Turner, L.A.4    Price, M.E.5    Naylor, A.M.6
  • 5
    • 0037445151 scopus 로고    scopus 로고
    • Theophylline: New perspectives for an old drug
    • Barnes PJ (2003a) Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med 167:813-818
    • (2003) Am. J. Respir. Crit. Care Med. , vol.167 , pp. 813-818
    • Barnes, P.J.1
  • 6
    • 0037215121 scopus 로고    scopus 로고
    • Therapy of chronic obstructive pulmonary disease
    • Barnes PJ (2003b) Therapy of chronic obstructive pulmonary disease. Pharmacol Ther 97:87-94
    • (2003) Pharmacol. Ther. , vol.97 , pp. 87-94
    • Barnes, P.J.1
  • 7
    • 28244462817 scopus 로고    scopus 로고
    • Theophylline in chronic obstructive pulmonary disease: New horizons
    • Barnes PJ (2005) Theophylline in chronic obstructive pulmonary disease: new horizons. Proc Am Thorac Soc 2:334-339
    • (2005) Proc. Am. Thorac. Soc. , vol.2 , pp. 334-339
    • Barnes, P.J.1
  • 8
    • 33748540402 scopus 로고    scopus 로고
    • Theophylline for COPD
    • Barnes P (2006) Theophylline for COPD. Thorax 61:742-744
    • (2006) Thorax , vol.61 , pp. 742-744
    • Barnes, P.1
  • 9
    • 20444480168 scopus 로고    scopus 로고
    • COPD: Current therapeutic interventions and future approaches
    • Barnes PJ, Stockley RA (2005) COPD: current therapeutic interventions and future approaches. Eur Respir J 25:1084-1106
    • (2005) Eur. Respir. J. , vol.25 , pp. 1084-1106
    • Barnes, P.J.1    Stockley, R.A.2
  • 10
    • 0014873336 scopus 로고
    • Effects of xanthine derivatives on lipolysis and on adenosine 3′, 5′-monophosphate phosphodiesterase activity
    • Beavo JA, Rogers NL, Crofford OB, Hardman JG, Sutherland EW, Newman EV (1970) Effects of xanthine derivatives on lipolysis and on adenosine 3′, 5′-monophosphate phosphodiesterase activity. Mol Pharmacol 6:597-603
    • (1970) Mol. Pharmacol. , vol.6 , pp. 597-603
    • Beavo, J.A.1    Rogers, N.L.2    Crofford, O.B.3    Hardman, J.G.4    Sutherland, E.W.5    Newman, E.V.6
  • 12
    • 0021325726 scopus 로고
    • Two classes of cAMP analogs which are selective for the two different cAMP-binding sites of type II protein kinase demonstrate synergism when added together to intact adipocytes
    • Beebe SJ, Holloway R, Rannels SR, Corbin JD (1984) Two classes of cAMP analogs which are selective for the two different cAMP-binding sites of type II protein kinase demonstrate synergism when added together to intact adipocytes. J Biol Chem 259:3539-3547
    • (1984) J. Biol. Chem. , vol.259 , pp. 3539-3547
    • Beebe, S.J.1    Holloway, R.2    Rannels, S.R.3    Corbin, J.D.4
  • 13
    • 0022401456 scopus 로고
    • Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis
    • Beebe SJ, Redmon JB, Blackmore PF, Corbin JD (1985) Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis. J Biol Chem 260:15781-15788
    • (1985) J. Biol. Chem. , vol.260 , pp. 15781-15788
    • Beebe, S.J.1    Redmon, J.B.2    Blackmore, P.F.3    Corbin, J.D.4
  • 14
  • 15
    • 0028941919 scopus 로고
    • Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: Topology of the catalytic domains
    • Beltman J, Becker DE, Butt E, Jensen GS, Rybalkin SD, Jastorff B, Beavo JA (1995) Characterization of cyclic nucleotide phosphodiesterases with cyclic GMP analogs: topology of the catalytic domains. Mol Pharmacol 47:330-339
    • (1995) Mol. Pharmacol. , vol.47 , pp. 330-339
    • Beltman, J.1    Becker, D.E.2    Butt, E.3    Jensen, G.S.4    Rybalkin, S.D.5    Jastorff, B.6    Beavo, J.A.7
  • 16
    • 33748686575 scopus 로고    scopus 로고
    • Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
    • Bender AT, Beavo JA (2006) Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 58:488-520
    • (2006) Pharmacol. Rev. , vol.58 , pp. 488-520
    • Bender, A.T.1    Beavo, J.A.2
  • 18
    • 0025272754 scopus 로고
    • Clinical pharmacology of caffeine
    • Benowitz NL (1990) Clinical pharmacology of caffeine. Annu Rev Med 41:277-288
    • (1990) Annu. Rev. Med. , vol.41 , pp. 277-288
    • Benowitz, N.L.1
  • 19
    • 0039090680 scopus 로고
    • The assay of glucagon and epinephrine with use of liver homogenates
    • Berthet J, Sutherland EW, Rall TW (1957) The assay of glucagon and epinephrine with use of liver homogenates. J Biol Chem 229:351-361
    • (1957) J. Biol. Chem. , vol.229 , pp. 351-361
    • Berthet, J.1    Sutherland, E.W.2    Rall, T.W.3
  • 21
    • 3042574999 scopus 로고    scopus 로고
    • Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation
    • Blount MA, Beasley A, Zoraghi R, Sekhar KR, Bessay EP, Francis SH, Corbin JD (2004) Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Mol Pharmacol 66:144-152
    • (2004) Mol. Pharmacol. , vol.66 , pp. 144-152
    • Blount, M.A.1    Beasley, A.2    Zoraghi, R.3    Sekhar, K.R.4    Bessay, E.P.5    Francis, S.H.6    Corbin, J.D.7
  • 22
    • 33751161472 scopus 로고    scopus 로고
    • A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization
    • Blount MA, Zoraghi R, Ke H, Bessay EP, Corbin JD, Francis SH (2006) A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization. Mol Pharmacol 70:1822-1831
    • (2006) Mol. Pharmacol. , vol.70 , pp. 1822-1831
    • Blount, M.A.1    Zoraghi, R.2    Ke, H.3    Bessay, E.P.4    Corbin, J.D.5    Francis, S.H.6
  • 25
    • 4944236929 scopus 로고    scopus 로고
    • What keeps us awake: The neuropharmacology of stimulants and wakefulness-promoting medications
    • Boutrel B, Koob GF (2004) What keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications. Sleep 27:1181-1194
    • (2004) Sleep , vol.27 , pp. 1181-1194
    • Boutrel, B.1    Koob, G.F.2
  • 28
    • 33646849221 scopus 로고    scopus 로고
    • Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism
    • Burnett AL, Bivalacqua TJ, Champion HC, Musicki B (2006) Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 67:1043-1048
    • (2006) Urology , vol.67 , pp. 1043-1048
    • Burnett, A.L.1    Bivalacqua, T.J.2    Champion, H.C.3    Musicki, B.4
  • 29
    • 33847612208 scopus 로고
    • Adenosine 3′, 5′-phosphate in biological materials. I. Purification and properties of cyclic 3′, 5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′, 5′-phosphate in human urine
    • Butcher RW, Sutherland EW (1962) Adenosine 3′, 5′-phosphate in biological materials. I. Purification and properties of cyclic 3′, 5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′, 5′-phosphate in human urine. J Biol Chem 237:1244-1250
    • (1962) J. Biol. Chem. , vol.237 , pp. 1244-1250
    • Butcher, R.W.1    Sutherland, E.W.2
  • 30
    • 0028923797 scopus 로고
    • Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: Topology of the catalytic sites and comparison with other cyclic AMP-binding proteins
    • Butt E, Beltman J, Becker DE, Jensen GS, Rybalkin SD, Jastorff B, Beavo JA (1995) Characterization of cyclic nucleotide phosphodiesterases with cyclic AMP analogs: topology of the catalytic sites and comparison with other cyclic AMP-binding proteins. Mol Pharmacol 47:340-347
    • (1995) Mol. Pharmacol. , vol.47 , pp. 340-347
    • Butt, E.1    Beltman, J.2    Becker, D.E.3    Jensen, G.S.4    Rybalkin, S.D.5    Jastorff, B.6    Beavo, J.A.7
  • 31
    • 23244437739 scopus 로고    scopus 로고
    • Phosphodiesterase type 5 inhibitors for erectile dysfunction
    • Carson CC, Lue TF (2005) Phosphodiesterase type 5 inhibitors for erectile dysfunction. BJU Int 96:257-280
    • (2005) BJU Int. , vol.96 , pp. 257-280
    • Carson, C.C.1    Lue, T.F.2
  • 32
    • 41949117255 scopus 로고    scopus 로고
    • An insight into the pharmacophores of phosphodiesterase-5 inhibitors from synthetic and crystal structural studies
    • Chen G, Wang H, Robinson H, Cai J, Wan Y, Ke H (2008) An insight into the pharmacophores of phosphodiesterase-5 inhibitors from synthetic and crystal structural studies. Biochem Pharmacol 75:1717-1728
    • (2008) Biochem. Pharmacol. , vol.75 , pp. 1717-1728
    • Chen, G.1    Wang, H.2    Robinson, H.3    Cai, J.4    Wan, Y.5    Ke, H.6
  • 33
    • 0015861774 scopus 로고
    • Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
    • Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108
    • (1973) Biochem. Pharmacol. , vol.22 , pp. 3099-3108
    • Cheng, Y.1    Prusoff, W.H.2
  • 34
    • 0023888871 scopus 로고
    • Caffeine and theophylline analogues: Correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors
    • Choi OH, Shamim MT, Padgett WL, Daly JW (1988) Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors. Life Sci 43:387-398
    • (1988) Life Sci. , vol.43 , pp. 387-398
    • Choi, O.H.1    Shamim, M.T.2    Padgett, W.L.3    Daly, J.W.4
  • 35
    • 34547839170 scopus 로고    scopus 로고
    • Caffeine content of prepackaged national-brand and private-label carbonated beverages
    • Chou K, Bell L (2007) Caffeine content of prepackaged national-brand and private-label carbonated beverages. J Food Sci 72: C337-C442
    • (2007) J. Food Sci. , vol.72
    • Chou, K.1    Bell, L.2
  • 36
    • 34447265905 scopus 로고    scopus 로고
    • Biochemistry and physiology of cyclic nucleotide phosphodiesterases: Essential components in cyclic nucleotide signaling
    • Conti M, Beavo J (2007) Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 76:481-511
    • (2007) Annu. Rev. Biochem. , vol.76 , pp. 481-511
    • Conti, M.1    Beavo, J.2
  • 37
    • 0020634734 scopus 로고
    • Studies of two different intrachain cGMP-binding sites of cGMP-dependent protein kinase
    • Corbin JD, Doskeland SO (1983) Studies of two different intrachain cGMP-binding sites of cGMP-dependent protein kinase. J Biol Chem 258:11391-11397
    • (1983) J. Biol. Chem. , vol.258 , pp. 11391-11397
    • Corbin, J.D.1    Doskeland, S.O.2
  • 38
    • 0033553509 scopus 로고    scopus 로고
    • Cyclic GMP phosphodiesterase-5: Target of sildenafil
    • Corbin JD, Francis SH (1999) Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem 274:13729-13732
    • (1999) J. Biol. Chem. , vol.274 , pp. 13729-13732
    • Corbin, J.D.1    Francis, S.H.2
  • 39
    • 0036332629 scopus 로고    scopus 로고
    • Pharmacology of phosphodiesterase-5 inhibitors
    • Corbin JD, Francis SH (2002) Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract 56:453-459
    • (2002) Int. J. Clin. Pract. , vol.56 , pp. 453-459
    • Corbin, J.D.1    Francis, S.H.2
  • 40
    • 4243194585 scopus 로고    scopus 로고
    • Vardenafil: Structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)
    • Corbin JD, Beasley A, Blount MA, Francis SH (2004) Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5). Neurochem Int 45:859-863
    • (2004) Neurochem. Int. , vol.45 , pp. 859-863
    • Corbin, J.D.1    Beasley, A.2    Blount, M.A.3    Francis, S.H.4
  • 41
  • 42
    • 33646578507 scopus 로고    scopus 로고
    • Tyrosine-612 in PDE5 contributes to higher affinity for vardenafil over sildenafil
    • Corbin J, Francis S, Zoraghi R (2006) Tyrosine-612 in PDE5 contributes to higher affinity for vardenafil over sildenafil. Int J Impot Res 18:251-257
    • (2006) Int. J. Impot Res. , vol.18 , pp. 251-257
    • Corbin, J.1    Francis, S.2    Zoraghi, R.3
  • 43
    • 85132536724 scopus 로고    scopus 로고
    • Photoreceptor phosphodiesterase (PDE6): A G-protein-activated PDE regulating visual excitation in rod and cone photoreceptor cells
    • Beavo J, Francis SH, Houslay MD eds, CRC, Boca Raton
    • Cote RH (2006) Photoreceptor phosphodiesterase (PDE6): a G-protein-activated PDE regulating visual excitation in rod and cone photoreceptor cells. In: Beavo J, Francis SH, Houslay MD (eds) Cyclic nucleotide phosphodiesterases in health and disease. CRC, Boca Raton, pp 165-193
    • (2006) Cyclic Nucleotide Phosphodiesterases in Health and Disease , pp. 165-193
    • Cote, R.H.1
  • 44
    • 33746469525 scopus 로고    scopus 로고
    • Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition
    • Dao KK, Teigen K, Kopperud R, Hodneland E, Schwede F, Christensen AE, Martinez A, Doskeland SO (2006) Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition. J Biol Chem 281:21500-21511
    • (2006) J. Biol. Chem. , vol.281 , pp. 21500-21511
    • Dao, K.K.1    Teigen, K.2    Kopperud, R.3    Hodneland, E.4    Schwede, F.5    Christensen, A.E.6    Martinez, A.7    Doskeland, S.O.8
  • 45
    • 0023178721 scopus 로고
    • Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand
    • Degerman E, Belfrage P, Newman AH, Rice KC, Manganiello VC (1987) Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand. J Biol Chem 262:5797-5807
    • (1987) J. Biol. Chem. , vol.262 , pp. 5797-5807
    • Degerman, E.1    Belfrage, P.2    Newman, A.H.3    Rice, K.C.4    Manganiello, V.C.5
  • 46
    • 0002332460 scopus 로고    scopus 로고
    • Effects of theophylline and non-selective xanthine derivatives on PDE isoenzymes and cellular function
    • Schudt C, Dent G, Rabe KF eds, Academic, San Diego
    • Dent G, Rabe K (1996) Effects of theophylline and non-selective xanthine derivatives on PDE isoenzymes and cellular function. In: Schudt C, Dent G, Rabe KF (eds) Handbook of immunopharmacology: phosphodiesterase inhibitors. Academic, San Diego, pp 41-64
    • (1996) Handbook of Immunopharmacology: Phosphodiesterase Inhibitors , pp. 41-64
    • Dent, G.1    Rabe, K.2
  • 48
    • 0038003861 scopus 로고    scopus 로고
    • Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159
    • Doh H, Shin CY, Son M, Ko JI, Yoo M, Kim SH, Kim WB (2002) Mechanism of erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Arch Pharm Res 25:873-878
    • (2002) Arch. Pharm. Res. , vol.25 , pp. 873-878
    • Doh, H.1    Shin, C.Y.2    Son, M.3    Ko, J.I.4    Yoo, M.5    Kim, S.H.6    Kim, W.B.7
  • 49
    • 0020724928 scopus 로고
    • Mapping of the two intrachain cyclic nucleotide binding sites of adenosine cyclic 3′, 5′-phosphate dependent protein kinase I
    • Doskeland SO, Ogreid D, Ekanger R, Sturm PA, Miller JP, Suva RH (1983) Mapping of the two intrachain cyclic nucleotide binding sites of adenosine cyclic 3′, 5′-phosphate dependent protein kinase I. Biochemistry 22:1094-1101
    • (1983) Biochemistry , vol.22 , pp. 1094-1101
    • Doskeland, S.O.1    Ogreid, D.2    Ekanger, R.3    Sturm, P.A.4    Miller, J.P.5    Suva, R.H.6
  • 50
    • 34748905609 scopus 로고    scopus 로고
    • Cyclic adenosine 3′, 5′-monophosphate (cAMP)-dependent protein kinases, but not exchange proteins directly activated by cAMP (Epac), mediate thyrotropin/cAMP-dependent regulation of thyroid cells
    • Dremier S, Milenkovic M, Blancquaert S, Dumont JE, Doskeland SO, Maenhaut C, Roger PP (2007) Cyclic adenosine 3′, 5′-monophosphate (cAMP)-dependent protein kinases, but not exchange proteins directly activated by cAMP (Epac), mediate thyrotropin/cAMP-dependent regulation of thyroid cells. Endocrinology 148:4612-4622
    • (2007) Endocrinology , vol.148 , pp. 4612-4622
    • Dremier, S.1    Milenkovic, M.2    Blancquaert, S.3    Dumont, J.E.4    Doskeland, S.O.5    Maenhaut, C.6    Roger, P.P.7
  • 51
    • 77957609109 scopus 로고    scopus 로고
    • Energyfiend.com, Energy Fiend
    • Energyfiend.com (2005a) Caffeine content of drinks. Energy Fiend
    • (2005) Caffeine Content of Drinks
  • 53
    • 0023774749 scopus 로고
    • Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites
    • Erneux C, Miot F (1988) Cyclic nucleotide analogs used to study phosphodiesterase catalytic and allosteric sites. Methods Enzymol 159:520-530
    • (1988) Methods Enzymol. , vol.159 , pp. 520-530
    • Erneux, C.1    Miot, F.2
  • 57
    • 0032546779 scopus 로고    scopus 로고
    • Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase
    • Fisher DA, Smith JF, Pillar JS, St Denis SH, Cheng JB (1998) Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J Biol Chem 273:15559-15564
    • (1998) J. Biol. Chem. , vol.273 , pp. 15559-15564
    • Fisher, D.A.1    Smith, J.F.2    Pillar, J.S.3    St. Denis, S.H.4    Cheng, J.B.5
  • 58
    • 1542441699 scopus 로고    scopus 로고
    • Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists
    • Francis SH, Corbin JD (2003) Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists. Curr Urol Rep 4:457-465
    • (2003) Curr. Urol. Rep. , vol.4 , pp. 457-465
    • Francis, S.H.1    Corbin, J.D.2
  • 59
    • 27744494899 scopus 로고    scopus 로고
    • Phosphodiesterase-5 inhibition: The molecular biology of erectile function and dysfunction
    • vi
    • Francis SH, Corbin JD (2005a) Phosphodiesterase-5 inhibition: the molecular biology of erectile function and dysfunction. Urol Clin N Am 32:419-429, vi
    • (2005) Urol. Clin. N. Am. , vol.32 , pp. 419-429
    • Francis, S.H.1    Corbin, J.D.2
  • 60
    • 33748886578 scopus 로고    scopus 로고
    • Sildenafil: Efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction
    • Francis SH, Corbin JD (2005b) Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction. Expert Opin Drug Metab Toxicol 1:283-293
    • (2005) Expert Opin. Drug Metab. Toxicol. , vol.1 , pp. 283-293
    • Francis, S.H.1    Corbin, J.D.2
  • 61
    • 0018871466 scopus 로고
    • Characterization of a novel cGMP binding protein from rat lung
    • Francis SH, Lincoln TM, Corbin JD (1980) Characterization of a novel cGMP binding protein from rat lung. J Biol Chem 255:620-626
    • (1980) J. Biol. Chem. , vol.255 , pp. 620-626
    • Francis, S.H.1    Lincoln, T.M.2    Corbin, J.D.3
  • 62
    • 0023803473 scopus 로고
    • Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase
    • Francis SH, Noblett BD, Todd BW, Wells JN, Corbin JD (1988) Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol Pharmacol 34:506-517
    • (1988) Mol. Pharmacol. , vol.34 , pp. 506-517
    • Francis, S.H.1    Noblett, B.D.2    Todd, B.W.3    Wells, J.N.4    Corbin, J.D.5
  • 66
    • 77957574694 scopus 로고    scopus 로고
    • Notes on the history of caffeine use
    • Fredholm BB ed, Springer, Heidelberg
    • Fredholm BB (2010) Notes on the history of caffeine use. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Fredholm, B.B.1
  • 67
    • 0033603598 scopus 로고    scopus 로고
    • Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)
    • Fujishige K, Kotera J, Michibata H, Yuasa K, Takebayashi S, Okumura K, Omori K (1999) Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A). J Biol Chem 274:18438-18445
    • (1999) J. Biol. Chem. , vol.274 , pp. 18438-18445
    • Fujishige, K.1    Kotera, J.2    Michibata, H.3    Yuasa, K.4    Takebayashi, S.5    Okumura, K.6    Omori, K.7
  • 68
    • 33644675179 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension: Therapeutic algorithm
    • Galie N, Branzi A (2005) Pulmonary arterial hypertension: therapeutic algorithm. Ital Heart J 6:856-860
    • (2005) Ital Heart J. , vol.6 , pp. 856-860
    • Galie, N.1    Branzi, A.2
  • 69
    • 0037409401 scopus 로고    scopus 로고
    • Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans
    • Gamanuma M, Yuasa K, Sasaki T, Sakurai N, Kotera J, Omori K (2003) Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans. Cell Signal 15:565-574
    • (2003) Cell. Signal , vol.15 , pp. 565-574
    • Gamanuma, M.1    Yuasa, K.2    Sasaki, T.3    Sakurai, N.4    Kotera, J.5    Omori, K.6
  • 70
    • 0028784301 scopus 로고
    • The type II isoform of cGMP-dependent protein kinase is dimeric and possesses regulatory and catalytic properties distinct from the type I isoforms
    • Gamm DM, Francis SH, Angelotti TP, Corbin JD, Uhler MD (1995) The type II isoform of cGMP-dependent protein kinase is dimeric and possesses regulatory and catalytic properties distinct from the type I isoforms. J Biol Chem 270:27380-27388
    • (1995) J. Biol. Chem. , vol.270 , pp. 27380-27388
    • Gamm, D.M.1    Francis, S.H.2    Angelotti, T.P.3    Corbin, J.D.4    Uhler, M.D.5
  • 71
    • 0017134183 scopus 로고
    • Inhibition of separated forms of phosphodiesterases from pig coronary arteries by uracils and by 7-substituted derivatives of 1-methyl-3- isobutylxanthine
    • Garst JE, Kramer GL, Wu YJ, Wells JN (1976) Inhibition of separated forms of phosphodiesterases from pig coronary arteries by uracils and by 7-substituted derivatives of 1-methyl-3-isobutylxanthine. J Med Chem 19:499-503
    • (1976) J. Med. Chem. , vol.19 , pp. 499-503
    • Garst, J.E.1    Kramer, G.L.2    Wu, Y.J.3    Wells, J.N.4
  • 73
    • 0035190801 scopus 로고    scopus 로고
    • Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil
    • Gibson A (2001) Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil. Eur J Pharmacol 411:1-10
    • (2001) Eur. J. Pharmacol. , vol.411 , pp. 1-10
    • Gibson, A.1
  • 74
    • 0023918102 scopus 로고
    • Characterization of a bovine cone photoreceptor phosphodiesterase purified by cyclic GMP-sepharose chromatography
    • Gillespie PG, Beavo JA (1988) Characterization of a bovine cone photoreceptor phosphodiesterase purified by cyclic GMP-sepharose chromatography. J Biol Chem 263:8133-8141
    • (1988) J. Biol. Chem. , vol.263 , pp. 8133-8141
    • Gillespie, P.G.1    Beavo, J.A.2
  • 76
    • 0021359546 scopus 로고
    • Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase
    • Grant PG, Colman RW (1984) Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry 23:1801-1807
    • (1984) Biochemistry , vol.23 , pp. 1801-1807
    • Grant, P.G.1    Colman, R.W.2
  • 77
    • 84933257734 scopus 로고
    • The action of theophylline with ethylene diamine on intrathecal and venous pressures in cardaic failure and on bronchial obstruction in cardaic failure and in bronchial asthma
    • Greene J, Paul W, Faller A (1937) The action of theophylline with ethylene diamine on intrathecal and venous pressures in cardaic failure and on bronchial obstruction in cardaic failure and in bronchial asthma. JAMA 109:1712-1715
    • (1937) JAMA , vol.109 , pp. 1712-1715
    • Greene, J.1    Paul, W.2    Faller, A.3
  • 78
    • 52949091483 scopus 로고    scopus 로고
    • Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels
    • Guerreiro S, Toulorge D, Hirsch E, Marien M, Sokoloff P, Michel PP (2008) Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Mol Pharmacol 74:980-989
    • (2008) Mol. Pharmacol. , vol.74 , pp. 980-989
    • Guerreiro, S.1    Toulorge, D.2    Hirsch, E.3    Marien, M.4    Sokoloff, P.5    Michel, P.P.6
  • 79
    • 77957598503 scopus 로고    scopus 로고
    • Methylxanthines and ryanodine receptor channels
    • Fredholm BB ed, Springer, Heidelberg
    • Guerreiro S, Marien M, Michel PP (2010) Methylxanthines and ryanodine receptor channels. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Guerreiro, S.1    Marien, M.2    Michel, P.P.3
  • 80
    • 0030971045 scopus 로고    scopus 로고
    • Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart
    • Han P, Zhu X, Michaeli T (1997) Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J Biol Chem 272:16152-16157
    • (1997) J. Biol. Chem. , vol.272 , pp. 16152-16157
    • Han, P.1    Zhu, X.2    Michaeli, T.3
  • 81
    • 0023683480 scopus 로고
    • Purification of calmodulin-stimulated cyclic nucleotide phosphodiesterase by monoclonal antibody affinity chromatography
    • Hansen RS, Charbonneau H, Beavo JA (1988) Purification of calmodulin-stimulated cyclic nucleotide phosphodiesterase by monoclonal antibody affinity chromatography. Methods Enzymol 159:543-557
    • (1988) Methods Enzymol. , vol.159 , pp. 543-557
    • Hansen, R.S.1    Charbonneau, H.2    Beavo, J.A.3
  • 82
    • 0022454622 scopus 로고
    • Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: A receptor for new cardiotonic drugs
    • Harrison SA, Reifsnyder DH, Gallis B, Cadd GG, Beavo JA (1986) Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol Pharmacol 29:506-514
    • (1986) Mol. Pharmacol. , vol.29 , pp. 506-514
    • Harrison, S.A.1    Reifsnyder, D.H.2    Gallis, B.3    Cadd, G.G.4    Beavo, J.A.5
  • 83
    • 77957600978 scopus 로고    scopus 로고
    • Methylxanthines and inflammatory cells
    • Fredholm BB ed, Springer, Heidelberg
    • Haskó G, Cronstein B (2010) Methylxanthines and inflammatory cells. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Haskó, G.1    Cronstein, B.2
  • 84
    • 58249087496 scopus 로고    scopus 로고
    • Words of wisdom. Re: The efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction
    • Hatzimouratidis K (2008) Words of wisdom. Re: the efficacy and safety of udenafil, a new selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction. Paick J-S, Kim SW, Yang DY, Kim JJ, Lee SW, Ahn TY, Choi HK, Suh J-K, Kim SC. Eur Urol 54:946-947
    • (2008) Eur. Urol. , vol.54 , pp. 946-947
    • Hatzimouratidis, K.1    Paick, J.-S.2    Kim, S.W.3    Yang, D.Y.4    Kim, J.J.5    Lee, S.W.6    Ahn, T.Y.7    Choi, H.K.8    Suh, J.-K.9    Kim, S.C.10
  • 85
    • 0001238207 scopus 로고
    • Successful treatment of persistent extreme dyspnea, "status asthmaticus"-use of theophylline enthlene diamine (aminophylline USP) intravenously
    • Herrmann G, Aynesworth M, Martin J (1937) Successful treatment of persistent extreme dyspnea, "status asthmaticus"-use of theophylline enthlene diamine (aminophylline USP) intravenously. Lab Clin Med 23:135-148
    • (1937) Lab. Clin. Med. , vol.23 , pp. 135-148
    • Herrmann, G.1    Aynesworth, M.2    Martin, J.3
  • 88
    • 1842581748 scopus 로고    scopus 로고
    • Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity
    • Huai Q, Liu Y, Francis SH, Corbin JD, Ke H (2004a) Crystal structures of phosphodiesterases 4 and 5 in complex with inhibitor 3-isobutyl-1-methylxanthine suggest a conformation determinant of inhibitor selectivity. J Biol Chem 279:13095-13101
    • (2004) J. Biol. Chem. , vol.279 , pp. 13095-13101
    • Huai, Q.1    Liu, Y.2    Francis, S.H.3    Corbin, J.D.4    Ke, H.5
  • 89
    • 3042795876 scopus 로고    scopus 로고
    • Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding
    • Huai Q, Wang H, Zhang W, Colman RW, Robinson H, Ke H (2004b) Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding. Proc Natl Acad Sci USA 101:9624-9629
    • (2004) Proc. Natl. Acad. Sci. USA , vol.101 , pp. 9624-9629
    • Huai, Q.1    Wang, H.2    Zhang, W.3    Colman, R.W.4    Robinson, H.5    Ke, H.6
  • 93
    • 0037173056 scopus 로고    scopus 로고
    • A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression
    • Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ (2002) A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA 99:8921-8926
    • (2002) Proc. Natl. Acad. Sci. USA , vol.99 , pp. 8921-8926
    • Ito, K.1    Lim, S.2    Caramori, G.3    Cosio, B.4    Chung, K.F.5    Adcock, I.M.6    Barnes, P.J.7
  • 94
    • 52149122499 scopus 로고    scopus 로고
    • Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats
    • Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY, Lim SJ (2008) Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats. Am J Nephrol 29:274-282
    • (2008) Am. J. Nephrol. , vol.29 , pp. 274-282
    • Jeong, K.H.1    Lee, T.W.2    Ihm, C.G.3    Lee, S.H.4    Moon, J.Y.5    Lim, S.J.6
  • 95
    • 0028985443 scopus 로고
    • Effect of TNF alpha production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:C
    • Kaplan JM, Herzyk DJ, Ruggieri EV, Bartus JO, Esser KM, Bugelski PJ (1995) Effect of TNF alpha production inhibitors BRL 61063 and pentoxifylline on the response of rats to poly I:C. Toxicology 95:187-196
    • (1995) Toxicology , vol.95 , pp. 187-196
    • Kaplan, J.M.1    Herzyk, D.J.2    Ruggieri, E.V.3    Bartus, J.O.4    Esser, K.M.5    Bugelski, P.J.6
  • 96
    • 70349320443 scopus 로고    scopus 로고
    • Structure, catalytic mechanism, and inhibitor selectivity of cyclic nucleotide phosphodiesterases
    • Beavo J, Francis SH, Houslay MD eds, CRC, Boca Raton
    • Ke H, Wang H (2006) Structure, catalytic mechanism, and inhibitor selectivity of cyclic nucleotide phosphodiesterases. In: Beavo J, Francis SH, Houslay MD (eds) Cyclic nucleotide phosphodiesterases in health and disease. CRC, Boca Raton, pp 607-625
    • (2006) Cyclic Nucleotide Phosphodiesterases in Health and Disease , pp. 607-625
    • Ke, H.1    Wang, H.2
  • 97
    • 33847689816 scopus 로고    scopus 로고
    • Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity
    • Ke H, Wang H (2007) Crystal structures of phosphodiesterases and implications on substrate specificity and inhibitor selectivity. Curr Top Med Chem 7:391-403
    • (2007) Curr. Top Med. Chem. , vol.7 , pp. 391-403
    • Ke, H.1    Wang, H.2
  • 99
    • 0033546738 scopus 로고    scopus 로고
    • Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP
    • DOI 10.1006/bbrc.1999.1013
    • Kotera J, Fujishige K, Yuasa K, Omori K (1999) Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP. Biochem Biophys Res Commun 261:551-557 (Pubitemid 29408096)
    • (1999) Biochemical and Biophysical Research Communications , vol.261 , Issue.3 , pp. 551-557
    • Kotera, J.1    Fujishige, K.2    Yuasa, K.3    Omori, K.4
  • 100
    • 67649566083 scopus 로고    scopus 로고
    • Phosphodiesterase 5 inhibition in heart failure: Mechanisms and clinical implications
    • Kumar P, Francis GS, Wilson Tang WH (2009) Phosphodiesterase 5 inhibition in heart failure: mechanisms and clinical implications. Nat Rev Cardiol 6:349-355
    • (2009) Nat. Rev. Cardiol. , vol.6 , pp. 349-355
    • Kumar, P.1    Francis, G.S.2    Wilson Tang, W.H.3
  • 101
    • 0024316840 scopus 로고
    • Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form
    • Lavan BE, Lakey T, Houslay MD (1989) Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form. Biochem Pharmacol 38:4123-4136
    • (1989) Biochem. Pharmacol. , vol.38 , pp. 4123-4136
    • Lavan, B.E.1    Lakey, T.2    Houslay, M.D.3
  • 102
    • 33746979212 scopus 로고    scopus 로고
    • Phosphodiesterase inhibitors in Raynaud's phenomenon
    • Levien TL (2006) Phosphodiesterase inhibitors in Raynaud's phenomenon. Ann Pharmacother 40:1388-1393
    • (2006) Ann. Pharmacother. , vol.40 , pp. 1388-1393
    • Levien, T.L.1
  • 103
    • 0030064790 scopus 로고    scopus 로고
    • Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3′, 5′-cyclic nucleotide phosphodiesterases
    • Loughney K, Martins TJ, Harris EA, Sadhu K, Hicks JB, Sonnenburg WK, Beavo JA, Ferguson K (1996) Isolation and characterization of cDNAs corresponding to two human calcium, calmodulin-regulated, 3′, 5′-cyclic nucleotide phosphodiesterases. J Biol Chem 271:796-806
    • (1996) J. Biol. Chem. , vol.271 , pp. 796-806
    • Loughney, K.1    Martins, T.J.2    Harris, E.A.3    Sadhu, K.4    Hicks, J.B.5    Sonnenburg, W.K.6    Beavo, J.A.7    Ferguson, K.8
  • 106
    • 0020038738 scopus 로고
    • Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues
    • Martins TJ, Mumby MC, Beavo JA (1982) Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues. J Biol Chem 257:1973-1979
    • (1982) J. Biol. Chem. , vol.257 , pp. 1973-1979
    • Martins, T.J.1    Mumby, M.C.2    Beavo, J.A.3
  • 112
    • 0029074582 scopus 로고
    • Erythro-9-(2-hydroxy-3-nonyl) adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes
    • Mery PF, Pavoine C, Pecker F, Fischmeister R (1995) Erythro-9-(2-hydroxy- 3-nonyl) adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol Pharmacol 48:121-130
    • (1995) Mol. Pharmacol. , vol.48 , pp. 121-130
    • Mery, P.F.1    Pavoine, C.2    Pecker, F.3    Fischmeister, R.4
  • 113
    • 0027164208 scopus 로고
    • Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae
    • Michaeli T, Bloom TJ, Martins T, Loughney K, Ferguson K, Riggs M, Rodgers L, Beavo JA, Wigler M (1993) Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae. J Biol Chem 268:12925-12932
    • (1993) J. Biol. Chem. , vol.268 , pp. 12925-12932
    • Michaeli, T.1    Bloom, T.J.2    Martins, T.3    Loughney, K.4    Ferguson, K.5    Riggs, M.6    Rodgers, L.7    Beavo, J.A.8    Wigler, M.9
  • 115
    • 0027994403 scopus 로고
    • Cyclic nucleotide phosphodiesterase isoenzymes in guinea-pig tracheal muscle and bronchorelaxation by alkylxanthines
    • Miyamoto K, Kurita M, Sakai R, Sanae F, Wakusawa S, Takagi K (1994) Cyclic nucleotide phosphodiesterase isoenzymes in guinea-pig tracheal muscle and bronchorelaxation by alkylxanthines. Biochem Pharmacol 48:1219-1223
    • (1994) Biochem. Pharmacol. , vol.48 , pp. 1219-1223
    • Miyamoto, K.1    Kurita, M.2    Sakai, R.3    Sanae, F.4    Wakusawa, S.5    Takagi, K.6
  • 116
    • 77957585770 scopus 로고    scopus 로고
    • Xanthines as adenosine receptor antagonists
    • Fredholm BB ed, Springer, Heidelberg
    • Müller C, Jacobson KA (2010) Xanthines as adenosine receptor antagonists. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Müller, C.1    Jacobson, K.A.2
  • 117
    • 0019426647 scopus 로고
    • Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines
    • Mushlin P, Boerth RC, Wells JN (1981) Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines. Mol Pharmacol 20:179-189
    • (1981) Mol. Pharmacol. , vol.20 , pp. 179-189
    • Mushlin, P.1    Boerth, R.C.2    Wells, J.N.3
  • 119
    • 44049087903 scopus 로고    scopus 로고
    • Caffeinated cocktails: Energy drink consumption, high-risk drinking, and alcohol-related consequences among college students
    • O'Brien M, McCoy T, Rhodes S, Wagoner A, Wolfson M (2008) Caffeinated cocktails: energy drink consumption, high-risk drinking, and alcohol-related consequences among college students. Acad Emerg Med 15:453-460
    • (2008) Acad. Emerg. Med. , vol.15 , pp. 453-460
    • O'Brien, M.1    McCoy, T.2    Rhodes, S.3    Wagoner, A.4    Wolfson, M.5
  • 120
    • 77957570893 scopus 로고    scopus 로고
    • Methylxanthines, inflammation and cancer: Fundamental mechanisms
    • Fredholm BB ed, Springer, Heidelberg
    • Ohta A, Sitkovsky M (2010) Methylxanthines, inflammation and cancer: Fundamental mechanisms. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Ohta, A.1    Sitkovsky, M.2
  • 121
    • 77957581881 scopus 로고    scopus 로고
    • Methylxanthines and the kidney
    • Fredholm BB ed, Springer, Heidelberg
    • Osswald H, Schnermann J (2010) Methylxanthines and the kidney. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Osswald, H.1    Schnermann, J.2
  • 122
    • 44349167164 scopus 로고    scopus 로고
    • Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac-and cAMP-dependent protein kinase-dependent processes
    • Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K, Doskeland SO, Kristiansen K (2008) Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac-and cAMP-dependent protein kinase-dependent processes. Mol Cell Biol 28:3804-3816
    • (2008) Mol. Cell. Biol. , vol.28 , pp. 3804-3816
    • Petersen, R.K.1    Madsen, L.2    Pedersen, L.M.3    Hallenborg, P.4    Hagland, H.5    Viste, K.6    Doskeland, S.O.7    Kristiansen, K.8
  • 124
    • 77957560460 scopus 로고    scopus 로고
    • Methylxanthines and sleep
    • Fredholm BB ed, Springer, Heidelberg
    • Porkka-Heiskanen T (2010) Methylxanthines and sleep. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Porkka-Heiskanen, T.1
  • 126
    • 0029072842 scopus 로고
    • Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants
    • Rabe KF, Magnussen H, Dent G (1995) Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J 8:637-642
    • (1995) Eur. Respir. J. , vol.8 , pp. 637-642
    • Rabe, K.F.1    Magnussen, H.2    Dent, G.3
  • 128
    • 0141532168 scopus 로고    scopus 로고
    • Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac
    • Rehmann H, Schwede F, Doskeland SO, Wittinghofer A, Bos JL (2003) Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac. J Biol Chem 278:38548-38556
    • (2003) J. Biol. Chem. , vol.278 , pp. 38548-38556
    • Rehmann, H.1    Schwede, F.2    Doskeland, S.O.3    Wittinghofer, A.4    Bos, J.L.5
  • 129
    • 0035030692 scopus 로고    scopus 로고
    • Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic amp-specific phosphodiesterase PDE4A10
    • Rena G, Begg F, Ross A, MacKenzie C, McPhee I, Campbell L, Huston E, Sullivan M, Houslay MD (2001) Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic amp-specific phosphodiesterase PDE4A10. Mol Pharmacol 59:996-1011
    • (2001) Mol. Pharmacol. , vol.59 , pp. 996-1011
    • Rena, G.1    Begg, F.2    Ross, A.3    MacKenzie, C.4    McPhee, I.5    Campbell, L.6    Huston, E.7    Sullivan, M.8    Houslay, M.D.9
  • 130
    • 15744384883 scopus 로고    scopus 로고
    • Requirement of intact adenosine A1 receptors for the diuretic and natriuretic of the methylxanthines theophylline and caffeine
    • Rieg T, Steigele H, Schnermann J, Richter K, Osswald H, Vallon V (2005) Requirement of intact adenosine A1 receptors for the diuretic and natriuretic of the methylxanthines theophylline and caffeine. J Pharmacol Exp Ther 313:403-419
    • (2005) J. Pharmacol. Exp. Ther. , vol.313 , pp. 403-419
    • Rieg, T.1    Steigele, H.2    Schnermann, J.3    Richter, K.4    Osswald, H.5    Vallon, V.6
  • 131
    • 0031006150 scopus 로고    scopus 로고
    • Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′, 5′-cyclic nucleotide phosphodiesterase
    • Rosman GJ, Martins TJ, Sonnenburg WK, Beavo JA, Ferguson K, Loughney K (1997) Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′, 5′-cyclic nucleotide phosphodiesterase. Gene 191:89-95
    • (1997) Gene , vol.191 , pp. 89-95
    • Rosman, G.J.1    Martins, T.J.2    Sonnenburg, W.K.3    Beavo, J.A.4    Ferguson, K.5    Loughney, K.6
  • 133
    • 0031712906 scopus 로고    scopus 로고
    • Heterologous expression and purification of recombinant rolipram-sensitive cyclic AMP-specific phosphodiesterases
    • Salanova M, Jin SC, Conti M (1998) Heterologous expression and purification of recombinant rolipram-sensitive cyclic AMP-specific phosphodiesterases. Methods 14:55-64
    • (1998) Methods , vol.14 , pp. 55-64
    • Salanova, M.1    Jin, S.C.2    Conti, M.3
  • 134
    • 33846374445 scopus 로고    scopus 로고
    • Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K (ATP) channels when administered at reperfusion following ischemia in rabbits
    • Salloum FN, Takenoshita Y, Ockaili RA, Daoud VP, Chou E, Yoshida KI, Kukreja RC (2006) Sildenafil and vardenafil but not nitroglycerin limit myocardial infarction through opening of mitochondrial K (ATP) channels when administered at reperfusion following ischemia in rabbits. J Mol Cell Cardiol 42:453-458
    • (2006) J. Mol. Cell. Cardiol. , vol.42 , pp. 453-458
    • Salloum, F.N.1    Takenoshita, Y.2    Ockaili, R.A.3    Daoud, V.P.4    Chou, E.5    Yoshida, K.I.6    Kukreja, R.C.7
  • 135
    • 0001174757 scopus 로고
    • On some points in the treatment and clinical history of asthma
    • Salter H (1859) On some points in the treatment and clinical history of asthma. Edinb Med J 4:1109-1115
    • (1859) Edinb. Med. J. , vol.4 , pp. 1109-1115
    • Salter, H.1
  • 136
    • 3543077168 scopus 로고    scopus 로고
    • Quantum mechanical study of the syn and anti conformations of solvated cyclic GMP
    • Salter E, Wierzbicki A, Sperl G, Thompson WJ (2003) Quantum mechanical study of the syn and anti conformations of solvated cyclic GMP. Struct Chem 14:527-533
    • (2003) Struct. Chem. , vol.14 , pp. 527-533
    • Salter, E.1    Wierzbicki, A.2    Sperl, G.3    Thompson, W.J.4
  • 138
    • 0037081859 scopus 로고    scopus 로고
    • Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation
    • Sasaki T, Kotera J, Omori K (2002) Novel alternative splice variants of rat phosphodiesterase 7B showing unique tissue-specific expression and phosphorylation. Biochem J 361:211-220
    • (2002) Biochem. J. , vol.361 , pp. 211-220
    • Sasaki, T.1    Kotera, J.2    Omori, K.3
  • 139
    • 0015074019 scopus 로고
    • Increase in the content of adenosine 3′, 5′-monophosphate in mouse forebrain during seizures and prevention of the increase by methylxanthines
    • Sattin A (1971) Increase in the content of adenosine 3′, 5′-monophosphate in mouse forebrain during seizures and prevention of the increase by methylxanthines. J Neurochem 18:1087-1096
    • (1971) J. Neurochem. , vol.18 , pp. 1087-1096
    • Sattin, A.1
  • 140
    • 0014699031 scopus 로고
    • The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′, 5′-phosphate content of guinea pig cerebral cortex slices
    • Sattin A, Rall TW (1970) The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′, 5′-phosphate content of guinea pig cerebral cortex slices. Mol Pharmacol 6:13-23
    • (1970) Mol. Pharmacol. , vol.6 , pp. 13-23
    • Sattin, A.1    Rall, T.W.2
  • 141
    • 0027418624 scopus 로고
    • Caffeine as an analgesic adjuvant: A review of pharmacology and mechanisms of action
    • Sawynok J, Yaksh TL (1993) Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev 45:43-85
    • (1993) Pharmacol. Rev. , vol.45 , pp. 43-85
    • Sawynok, J.1    Yaksh, T.L.2
  • 144
    • 0002994013 scopus 로고    scopus 로고
    • Design and synthesis of xanthines and cyclic GMP analogues as potent inhibitors of PDE5
    • Schudt C, Dent G, Rabe KF eds, Academic, New York
    • Sekhar KR, Grondin P, Francis SH, Corbin JD (1996) Design and synthesis of xanthines and cyclic GMP analogues as potent inhibitors of PDE5. In: Schudt C, Dent G, Rabe KF (eds) Phosphodiesterase inhibitors. Academic, New York, pp 135-146
    • (1996) Phosphodiesterase Inhibitors , pp. 135-146
    • Sekhar, K.R.1    Grondin, P.2    Francis, S.H.3    Corbin, J.D.4
  • 145
    • 0022559490 scopus 로고
    • 2+-dependent phosphorylation and dephosphorylation of 63-kDa subunit-containing bovine brain calmodulin- stimulated cyclic nucleotide phosphodiesterase isozyme
    • 2+-dependent phosphorylation and dephosphorylation of 63-kDa subunit-containing bovine brain calmodulin-stimulated cyclic nucleotide phosphodiesterase isozyme. J Biol Chem 261:1322-1328
    • (1986) J. Biol. Chem. , vol.261 , pp. 1322-1328
    • Sharma, R.K.1    Wang, J.H.2
  • 146
    • 0021207286 scopus 로고
    • Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies
    • Sharma RK, Adachi AM, Adachi K, Wang JH (1984) Demonstration of bovine brain calmodulindependent cyclic nucleotide phosphodiesterase isozymes by monoclonal antibodies. J Biol Chem 259:9248-9254 (Pubitemid 14098913)
    • (1984) Journal of Biological Chemistry , vol.259 , Issue.14 , pp. 9248-9254
    • Sharma, R.K.1    Adachi, A.-M.2    Adachi, K.3    Wang, J.H.4
  • 148
    • 0018772403 scopus 로고
    • Alkylxanthines: Inhibition of adenosineelicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity
    • Smellie FW, Davis CW, Daly JW, Wells JN (1979) Alkylxanthines: inhibition of adenosineelicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity. Life Sci 24:2475-2482
    • (1979) Life Sci. , vol.24 , pp. 2475-2482
    • Smellie, F.W.1    Davis, C.W.2    Daly, J.W.3    Wells, J.N.4
  • 149
    • 77957561729 scopus 로고    scopus 로고
    • Theobromine and the pharmacology of cocoa
    • Fredholm BB ed, Springer, Heidelberg
    • Smit HJ (2010) Theobromine and the pharmacology of cocoa. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Smit, H.J.1
  • 151
    • 0032546924 scopus 로고    scopus 로고
    • Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases
    • Soderling SH, Bayuga SJ, Beavo JA (1998) Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J Biol Chem 273:15553-15558
    • (1998) J. Biol. Chem. , vol.273 , pp. 15553-15558
    • Soderling, S.H.1    Bayuga, S.J.2    Beavo, J.A.3
  • 153
    • 0029590775 scopus 로고
    • Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases
    • Sonnenburg WK, Seger D, Kwak KS, Huang J, Charbonneau H, Beavo JA (1995) Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases. J Biol Chem 270:30989-31000
    • (1995) J. Biol. Chem. , vol.270 , pp. 30989-31000
    • Sonnenburg, W.K.1    Seger, D.2    Kwak, K.S.3    Huang, J.4    Charbonneau, H.5    Beavo, J.A.6
  • 154
    • 84995315685 scopus 로고    scopus 로고
    • Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction
    • Stief C, Porst H, Saenz De Tejada I, Ulbrich E, Beneke M (2004) Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction. Int J Clin Pract 58:230-239
    • (2004) Int. J. Clin. Pract. , vol.58 , pp. 230-239
    • Stief, C.1    Porst, H.2    De Tejada, S.I.3    Ulbrich, E.4    Beneke, M.5
  • 155
    • 42749084255 scopus 로고    scopus 로고
    • A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia
    • Stief CG, Porst H, Neuser D, Beneke M, Ulbrich E (2008) A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. Eur Urol 53:1236-1244
    • (2008) Eur. Urol. , vol.53 , pp. 1236-1244
    • Stief, C.G.1    Porst, H.2    Neuser, D.3    Beneke, M.4    Ulbrich, E.5
  • 156
    • 34548125299 scopus 로고    scopus 로고
    • Novel N7-and N1-substituted cGMP derivatives are potent activators of cyclic nucleotide-gated channels
    • Strassmaier T, Karpen JW (2007) Novel N7-and N1-substituted cGMP derivatives are potent activators of cyclic nucleotide-gated channels. J Med Chem 50:4186-4194
    • (2007) J. Med. Chem. , vol.50 , pp. 4186-4194
    • Strassmaier, T.1    Karpen, J.W.2
  • 157
    • 0028344025 scopus 로고
    • Anti-inflammatory effects of low-dose oral theophylline in atopic asthma
    • Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J (1994a) Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 343:1006-1008
    • (1994) Lancet , vol.343 , pp. 1006-1008
    • Sullivan, P.1    Bekir, S.2    Jaffar, Z.3    Page, C.4    Jeffery, P.5    Costello, J.6
  • 160
    • 0001559662 scopus 로고
    • Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles
    • Sutherland EW, Rall TW (1958) Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. J Biol Chem 232:1077-1091
    • (1958) J. Biol. Chem. , vol.232 , pp. 1077-1091
    • Sutherland, E.W.1    Rall, T.W.2
  • 161
    • 0021772492 scopus 로고
    • Guanosine cyclic 3′, 5′-phosphate dependent protein kinase, a chimeric protein homologous with two separate protein families
    • Takio K, Wade RD, Smith SB, Krebs EG, Walsh KA, Titani K (1984) Guanosine cyclic 3′, 5′-phosphate dependent protein kinase, a chimeric protein homologous with two separate protein families. Biochemistry 23:4207-4218
    • (1984) Biochemistry , vol.23 , pp. 4207-4218
    • Takio, K.1    Wade, R.D.2    Smith, S.B.3    Krebs, E.G.4    Walsh, K.A.5    Titani, K.6
  • 162
    • 33748314488 scopus 로고    scopus 로고
    • Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35
    • Taniguchi Y, Tonai-Kachi H, Shinjo K (2006) Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett 580:5003-5008
    • (2006) FEBS Lett. , vol.580 , pp. 5003-5008
    • Taniguchi, Y.1    Tonai-Kachi, H.2    Shinjo, K.3
  • 163
    • 0025041146 scopus 로고
    • Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase
    • Thomas MK, Francis SH, Corbin JD (1990) Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase. J Biol Chem 265:14964-14970
    • (1990) J. Biol. Chem. , vol.265 , pp. 14964-14970
    • Thomas, M.K.1    Francis, S.H.2    Corbin, J.D.3
  • 164
    • 0026444440 scopus 로고
    • Partial mapping of cyclic nucleotide sites and studies of regulatory mechanisms of phosphodiesterases using cyclic nucleotide analogues
    • Thomas MK, Francis SH, Beebe SJ, Gettys TW, Corbin JD (1992) Partial mapping of cyclic nucleotide sites and studies of regulatory mechanisms of phosphodiesterases using cyclic nucleotide analogues. Adv Second Messenger Phosphoprotein Res 25:45-53
    • (1992) Adv. Second Messenger Phosphoprotein Res. , vol.25 , pp. 45-53
    • Thomas, M.K.1    Francis, S.H.2    Beebe, S.J.3    Gettys, T.W.4    Corbin, J.D.5
  • 165
    • 0025999955 scopus 로고
    • Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function
    • Review 195 refs
    • Thompson WJ (1991) Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. [Review] [195 refs]. Pharmacol Ther 51:13-33
    • (1991) Pharmacol. Ther. , vol.51 , pp. 13-33
    • Thompson, W.J.1
  • 166
    • 77957550648 scopus 로고    scopus 로고
    • Methylxanthines in asthma
    • Fredholm BB ed, Springer, Heidelberg
    • Tilley SL (2010) Methylxanthines in asthma. In: Fredholm BB (ed) Methylxanthines. Springer, Heidelberg
    • (2010) Methylxanthines
    • Tilley, S.L.1
  • 167
    • 0035869052 scopus 로고    scopus 로고
    • Treatment of intermittent claudication with pentoxifylline and cilostazol
    • Tjon JA, Riemann LE (2001) Treatment of intermittent claudication with pentoxifylline and cilostazol. Am J Health Syst Pharm 58:485-496
    • (2001) Am. J. Health Syst. Pharm. , vol.58 , pp. 485-496
    • Tjon, J.A.1    Riemann, L.E.2
  • 168
    • 44949156264 scopus 로고    scopus 로고
    • Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets
    • Toque HA, Teixeira CE, Priviero FB, Morganti RP, Antunes E, De Nucci G (2008) Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets. Br J Pharmacol 154:787-796
    • (2008) Br. J. Pharmacol. , vol.154 , pp. 787-796
    • Toque, H.A.1    Teixeira, C.E.2    Priviero, F.B.3    Morganti, R.P.4    Antunes, E.5    De Nucci, G.6
  • 170
    • 0032513145 scopus 로고    scopus 로고
    • Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase
    • Turko IV, Francis SH, Corbin JD (1998) Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase. J Biol Chem 273:6460-6466
    • (1998) J. Biol. Chem. , vol.273 , pp. 6460-6466
    • Turko, I.V.1    Francis, S.H.2    Corbin, J.D.3
  • 171
    • 0032993016 scopus 로고    scopus 로고
    • Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5) by sildenafil and related compounds
    • Turko IV, Ballard SA, Francis SH, Corbin JD (1999) Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5) by sildenafil and related compounds. Mol Pharmacol 56:124-130
    • (1999) Mol. Pharmacol. , vol.56 , pp. 124-130
    • Turko, I.V.1    Ballard, S.A.2    Francis, S.H.3    Corbin, J.D.4
  • 173
    • 0031578230 scopus 로고    scopus 로고
    • Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D
    • Wang P, Myers JG, Wu P, Cheewatrakoolpong B, Egan RW, Billah MM (1997) Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D. Biochem Biophys Res Commun 234:320-324
    • (1997) Biochem. Biophys. Res. Commun. , vol.234 , pp. 320-324
    • Wang, P.1    Myers, J.G.2    Wu, P.3    Cheewatrakoolpong, B.4    Egan, R.W.5    Billah, M.M.6
  • 175
    • 24744456706 scopus 로고    scopus 로고
    • Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7
    • Wang H, Liu Y, Chen Y, Robinson H, Ke H (2005) Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7. J Biol Chem 280:30949-30955
    • (2005) J. Biol. Chem. , vol.280 , pp. 30949-30955
    • Wang, H.1    Liu, Y.2    Chen, Y.3    Robinson, H.4    Ke, H.5
  • 178
    • 34447251539 scopus 로고    scopus 로고
    • The molecular basis for different recognition of substrates by phosphodiesterase families 4 and 10
    • Wang H, Robinson H, Ke H (2007b) The molecular basis for different recognition of substrates by phosphodiesterase families 4 and 10. J Mol Biol 371:302-307
    • (2007) J. Mol. Biol. , vol.371 , pp. 302-307
    • Wang, H.1    Robinson, H.2    Ke, H.3
  • 179
    • 57049103481 scopus 로고    scopus 로고
    • Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity
    • Wang H, Yan Z, Yang S, Cai J, Robinson H, Ke H (2008a) Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity. Biochemistry 47:12760-12768
    • (2008) Biochemistry , vol.47 , pp. 12760-12768
    • Wang, H.1    Yan, Z.2    Yang, S.3    Cai, J.4    Robinson, H.5    Ke, H.6
  • 180
    • 37349101070 scopus 로고    scopus 로고
    • Conformational variations of both phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil
    • Wang H, Ye M, Robinson H, Francis SH, Ke H (2008b) Conformational variations of both phosphodiesterase-5 and inhibitors provide the structural basis for the physiological effects of vardenafil and sildenafil. Mol Pharmacol 73:104-110
    • (2008) Mol. Pharmacol. , vol.73 , pp. 104-110
    • Wang, H.1    Ye, M.2    Robinson, H.3    Francis, S.H.4    Ke, H.5
  • 181
    • 35148897384 scopus 로고    scopus 로고
    • N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization
    • Weeks JL 2nd, Zoraghi R, Francis SH, Corbin JD (2007) N-Terminal domain of phosphodiesterase-11A4 (PDE11A4) decreases affinity of the catalytic site for substrates and tadalafil, and is involved in oligomerization. Biochemistry 46:10353-10364
    • (2007) Biochemistry , vol.46 , pp. 10353-10364
    • Weeks II, J.L.1    Zoraghi, R.2    Francis, S.H.3    Corbin, J.D.4
  • 182
    • 0019444366 scopus 로고
    • Phosphodiesterase inhibitors as tools in cyclic nucleotide research: A precautionary comment
    • Wells JN, Kramer GL (1981) Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment. Mol Cell Endocrinol 23:1-9
    • (1981) Mol. Cell. Endocrinol. , vol.23 , pp. 1-9
    • Wells, J.N.1    Kramer, G.L.2
  • 183
    • 0019502743 scopus 로고
    • Inhibition of separated forms of cyclic nucleotide phosphodiesterase from pig coronary arteries by 1, 3-disubstituted and 1, 3, 8-trisubstituted xanthines
    • Wells JN, Garst JE, Kramer GL (1981) Inhibition of separated forms of cyclic nucleotide phosphodiesterase from pig coronary arteries by 1, 3-disubstituted and 1, 3, 8-trisubstituted xanthines. J Med Chem 24:954-958
    • (1981) J. Med. Chem. , vol.24 , pp. 954-958
    • Wells, J.N.1    Garst, J.E.2    Kramer, G.L.3
  • 184
    • 0024361274 scopus 로고
    • The cDNA of the two isoforms of bovine cGMP-dependent protein kinase
    • Wernet W, Flockerzi V, Hofmann F (1989) The cDNA of the two isoforms of bovine cGMP-dependent protein kinase. FEBS Lett 251:191-196
    • (1989) FEBS Lett. , vol.251 , pp. 191-196
    • Wernet, W.1    Flockerzi, V.2    Hofmann, F.3
  • 185
    • 0024523027 scopus 로고
    • Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta
    • Wolfe L, Corbin JD, Francis SH (1989) Characterization of a novel isozyme of cGMP-dependent protein kinase from bovine aorta. J Biol Chem 264:7734-7741 (Pubitemid 19119197)
    • (1989) Journal of Biological Chemistry , vol.264 , Issue.13 , pp. 7734-7741
    • Wolfe, L.1    Corbin, J.D.2    Francis, S.H.3
  • 186
    • 0003186043 scopus 로고
    • The relationship of epinephrine and glucagon to liver phosphorylase. II. Enzymatic inactivation of liver phosphorylase
    • Wosilait WD, Sutherland EW (1956) The relationship of epinephrine and glucagon to liver phosphorylase. II. Enzymatic inactivation of liver phosphorylase. J Biol Chem 218:469-481
    • (1956) J. Biol. Chem. , vol.218 , pp. 469-481
    • Wosilait, W.D.1    Sutherland, E.W.2
  • 188
    • 0029845929 scopus 로고    scopus 로고
    • The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner
    • Yan C, Zhao AZ, Bentley JK, Beavo JA (1996) The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner. J Biol Chem 271:25699-25706
    • (1996) J. Biol. Chem. , vol.271 , pp. 25699-25706
    • Yan, C.1    Zhao, A.Z.2    Bentley, J.K.3    Beavo, J.A.4
  • 190
    • 66249143769 scopus 로고    scopus 로고
    • Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine
    • Yang JN, Chen JF, Fredholm BB (2009b) Physiological roles of A1 and A2A adenosine receptors in regulating heart rate, body temperature, and locomotion as revealed using knockout mice and caffeine. Am J Physiol Heart Circ Physiol 296: H1141-H1149
    • (2009) Am. J. Physiol. Heart Circ. Physiol. , vol.296
    • Yang, J.N.1    Chen, J.F.2    Fredholm, B.B.3
  • 191
    • 66349092002 scopus 로고    scopus 로고
    • Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling
    • Yu L, Coelho JE, Zhang X, Fu Y, Tillman A, Karaoz U, Fredholm BB, Weng Z, Chen JF (2009) Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A 2A receptor knockout mice with microarray profiling. Physiol Genomics 37:199-210
    • (2009) Physiol. Genomics , vol.37 , pp. 199-210
    • Yu, L.1    Coelho, J.E.2    Zhang, X.3    Fu, Y.4    Tillman, A.5    Karaoz, U.6    Fredholm, B.B.7    Weng, Z.8    Chen, J.F.9
  • 192
    • 0034819381 scopus 로고    scopus 로고
    • Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): Comparison of rat and human PDE11A splicing variants
    • Yuasa K, Ohgaru T, Asahina M, Omori K (2001) Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A): comparison of rat and human PDE11A splicing variants. Eur J Biochem 268:4440-4448
    • (2001) Eur. J. Biochem. , vol.268 , pp. 4440-4448
    • Yuasa, K.1    Ohgaru, T.2    Asahina, M.3    Omori, K.4
  • 193
    • 85132515827 scopus 로고    scopus 로고
    • Crystal structure of phosphodiesterase families and the potential for rational drug design
    • Beavo J, Francis SH, Houslay MD eds, CRC, Boca Raton
    • Zhang K Y J (2006) Crystal structure of phosphodiesterase families and the potential for rational drug design. In: Beavo J, Francis SH, Houslay MD (eds) Cyclic nucleotide phosphodiesterase in health and disease. CRC, Boca Raton, pp 583-605
    • (2006) Cyclic Nucleotide Phosphodiesterase in Health and Disease , pp. 583-605
    • Zhang, K.Y.J.1
  • 194
    • 27244459472 scopus 로고    scopus 로고
    • Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors
    • Zhang X, Feng Q, Cote RH (2005) Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors. Invest Ophthalmol Vis Sci 46:3060-3066
    • (2005) Invest. Ophthalmol. Vis. Sci. , vol.46 , pp. 3060-3066
    • Zhang, X.1    Feng, Q.2    Cote, R.H.3
  • 195
    • 33646847852 scopus 로고    scopus 로고
    • Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: Its orientation impacts cGMP but not cAMP affinity
    • Zoraghi R, Corbin JD, Francis SH (2006) Phosphodiesterase-5 Gln817 is critical for cGMP, vardenafil, or sildenafil affinity: its orientation impacts cGMP but not cAMP affinity. J Biol Chem 281:5553-5558
    • (2006) J. Biol. Chem. , vol.281 , pp. 5553-5558
    • Zoraghi, R.1    Corbin, J.D.2    Francis, S.H.3
  • 196
    • 36749009575 scopus 로고    scopus 로고
    • Critical amino acids in phosphodiesterase-5 catalytic site that provide for high-affinity interaction with cGMP and inhibitors
    • Zoraghi R, Francis SH, Corbin JD (2007) Critical amino acids in phosphodiesterase-5 catalytic site that provide for high-affinity interaction with cGMP and inhibitors. Biochemistry 46:13554-13563
    • (2007) Biochemistry , vol.46 , pp. 13554-13563
    • Zoraghi, R.1    Francis, S.H.2    Corbin, J.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.